Business Description
Nova Leap Health Corp
NAICS : 623312
SIC : 8621
ISIN : CA66980G1090
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.52 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | -12.26 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.47 | |||||
Beneish M-Score | -3 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.6 | |||||
3-Year EBITDA Growth Rate | 32.6 | |||||
3-Year EPS without NRI Growth Rate | 9.1 | |||||
3-Year FCF Growth Rate | 7.7 | |||||
3-Year Book Growth Rate | 25.1 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.6 | |||||
9-Day RSI | 36.97 | |||||
14-Day RSI | 40.74 | |||||
6-1 Month Momentum % | 57.58 | |||||
12-1 Month Momentum % | 30 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.3 | |||||
Quick Ratio | 1.3 | |||||
Cash Ratio | 0.48 | |||||
Days Sales Outstanding | 23.94 | |||||
Days Payable | 26.76 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.6 | |||||
Shareholder Yield % | 17.68 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 36.25 | |||||
Operating Margin % | -0.7 | |||||
Net Margin % | -4.07 | |||||
FCF Margin % | 5.15 | |||||
ROE % | -5.75 | |||||
ROA % | -4.61 | |||||
ROIC % | -0.65 | |||||
ROC (Joel Greenblatt) % | -55.68 | |||||
ROCE % | -5.9 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 16.1 | |||||
Price-to-Owner-Earnings | 110 | |||||
PS Ratio | 0.54 | |||||
PB Ratio | 0.75 | |||||
Price-to-Tangible-Book | 6.11 | |||||
Price-to-Free-Cash-Flow | 10.48 | |||||
Price-to-Operating-Cash-Flow | 10 | |||||
EV-to-EBIT | -12.78 | |||||
EV-to-EBITDA | -86.36 | |||||
EV-to-Revenue | 0.57 | |||||
EV-to-Forward-Revenue | 0.5 | |||||
EV-to-FCF | 11.08 | |||||
Price-to-Projected-FCF | 0.48 | |||||
Earnings Yield (Greenblatt) % | -7.82 | |||||
FCF Yield % | 9.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Nova Leap Health Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 35.702 | ||
EPS (TTM) (C$) | -0.018 | ||
Beta | 2.04 | ||
Volatility % | 89.29 | ||
14-Day RSI | 40.74 | ||
14-Day ATR (C$) | 0.009589 | ||
20-Day SMA (C$) | 0.24 | ||
12-1 Month Momentum % | 30 | ||
52-Week Range (C$) | 0.125 - 0.3 | ||
Shares Outstanding (Mil) | 86.21 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Nova Leap Health Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Nova Leap Health Corp Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Nova Leap Health Corp Frequently Asked Questions
What is Nova Leap Health Corp(TSXV:NLH)'s stock price today?
When is next earnings date of Nova Leap Health Corp(TSXV:NLH)?
Does Nova Leap Health Corp(TSXV:NLH) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |